Skip to main content
Top

29-10-2024 | Neuroblastoma | Research

Inter-observer variability in assessing image-defined risk factors: implications for risk stratification in locoregional abdominopelvic neuroblastoma

Authors: Haoru Wang, Mingjing Chen, Ling He, Xin Chen

Published in: Abdominal Radiology

Login to get access

Abstract

Purpose

Risk stratification for locoregional neuroblastoma partially relies on image-defined risk factors (IDRFs). This study aimed to evaluate how inter-observer variability in assessing IDRFs impacts risk stratification in locoregional abdominopelvic neuroblastoma.

Methods

A retrospective analysis was conducted on 123 patients who underwent upfront contrast-enhanced CT scans. Two radiologists independently assessed the presence of IDRFs. Patients were staged as either L1 (IDRF-negative) or L2 (IDRF-positive) according to the International Neuroblastoma Risk Group Staging System. Based on the radiologists’ evaluations, 97 cases with sufficient clinical data were classified into risk groups using the revised Children’s Oncology Group neuroblastoma risk classifier. The kappa values and 95% confidence intervals (CIs) were calculated to assess inter-radiologist agreement on IDRF evaluation and risk stratification.

Results

There was low agreement between radiologists in assessing L1/L2 status with a kappa value of 0.28 (95% CI: 0.14–0.42). However, agreement for evaluating the number of IDRFs was good, with an intraclass correlation coefficient of 0.73 (95% CI: 0.64–0.80). Based on the first radiologist’s evaluation, 13 patients were classified as low-risk, 52 as intermediate-risk, and 32 as high-risk. Based on the second radiologist’s evaluation, 37 patients were classified as low-risk, 37 as intermediate-risk, and 23 as high-risk. The kappa value for risk stratification between the two radiologists was 0.47 (95% CI: 0.33–0.62).

Conclusion

Inter-observer variability in assessing IDRF presence may affect risk stratification in locoregional abdominopelvic neuroblastoma.
Literature
2.
go back to reference Zhou J, Du H, Cai W. Narrative review: precision medicine applications in neuroblastoma-current status and future prospects. Transl Pediatr 2024; 13:164–177.CrossRefPubMedPubMedCentral Zhou J, Du H, Cai W. Narrative review: precision medicine applications in neuroblastoma-current status and future prospects. Transl Pediatr 2024; 13:164–177.CrossRefPubMedPubMedCentral
3.
go back to reference Zhang D, Kaweme NM, Duan P, et al. Upfront Treatment of Pediatric High-Risk Neuroblastoma With Chemotherapy, Surgery, and Radiotherapy Combination: The CCCG-NB-2014 Protocol. Front Oncol 2021; 11:745794.CrossRefPubMedPubMedCentral Zhang D, Kaweme NM, Duan P, et al. Upfront Treatment of Pediatric High-Risk Neuroblastoma With Chemotherapy, Surgery, and Radiotherapy Combination: The CCCG-NB-2014 Protocol. Front Oncol 2021; 11:745794.CrossRefPubMedPubMedCentral
4.
go back to reference Cohn SL, Pearson AD, London WB, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 2009: 27:289–297.CrossRefPubMedPubMedCentral Cohn SL, Pearson AD, London WB, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 2009: 27:289–297.CrossRefPubMedPubMedCentral
5.
go back to reference Irwin MS, Naranjo A, Zhang FF, et al. Revised Neuroblastoma Risk Classification System: A Report From the Children’s Oncology Group. J Clin Oncol 2021; 39:3229–3241.CrossRefPubMedPubMedCentral Irwin MS, Naranjo A, Zhang FF, et al. Revised Neuroblastoma Risk Classification System: A Report From the Children’s Oncology Group. J Clin Oncol 2021; 39:3229–3241.CrossRefPubMedPubMedCentral
6.
go back to reference Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 2009; 27:298–303.CrossRefPubMedPubMedCentral Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 2009; 27:298–303.CrossRefPubMedPubMedCentral
8.
go back to reference Morin CE, Hasweh R, Anton C, et al. Gadolinium-based contrast media does not improve the staging of neuroblastoma image-defined risk factors at diagnosis. Pediatr Blood Cancer 2024; 71:e30724.CrossRefPubMed Morin CE, Hasweh R, Anton C, et al. Gadolinium-based contrast media does not improve the staging of neuroblastoma image-defined risk factors at diagnosis. Pediatr Blood Cancer 2024; 71:e30724.CrossRefPubMed
9.
go back to reference Macdonald IR, Farhat Z, Amoako-Tuffor Y, et al. MR imaging of pediatric neuroblastoma: is gadolinium enhancement necessary for evaluation of image-defined-risk factors? Can Assoc Radiol J. 2024;75:401–11.CrossRefPubMed Macdonald IR, Farhat Z, Amoako-Tuffor Y, et al. MR imaging of pediatric neuroblastoma: is gadolinium enhancement necessary for evaluation of image-defined-risk factors? Can Assoc Radiol J. 2024;75:401–11.CrossRefPubMed
10.
go back to reference Brisse HJ, McCarville MB, Granata C, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 2011; 261:243–257.CrossRefPubMed Brisse HJ, McCarville MB, Granata C, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 2011; 261:243–257.CrossRefPubMed
11.
go back to reference Sosnowska-Sienkiewicz P, Mańkowski P, Wojas A, et al. The Important Role of the Radiologist in Determining the Indications for the Surgical Treatment of Neuroblastoma with Vascular Image-Defined Risk Factors: A Case Report. Medicina (Kaunas) 2021; 57:279.CrossRefPubMed Sosnowska-Sienkiewicz P, Mańkowski P, Wojas A, et al. The Important Role of the Radiologist in Determining the Indications for the Surgical Treatment of Neuroblastoma with Vascular Image-Defined Risk Factors: A Case Report. Medicina (Kaunas) 2021; 57:279.CrossRefPubMed
12.
go back to reference Mohamed AHA, Mahmoud IH, Seif El Dein HM, et al. Assessment of the validity of image-defined risk factors (IDRFs) in abdominal neuroblastoma. Egypt J Radiol Nucl Med 2020; 51:88.CrossRef Mohamed AHA, Mahmoud IH, Seif El Dein HM, et al. Assessment of the validity of image-defined risk factors (IDRFs) in abdominal neuroblastoma. Egypt J Radiol Nucl Med 2020; 51:88.CrossRef
13.
go back to reference van Heerden J, Esterhuizen TM, Hendricks M, et al. The Association of Clinical Characteristics and Tumour Markers With Image-Defined Risk Factors in the Management of Neuroblastoma in South Africa. Clin Oncol (R Coll Radiol) 2022; 34:e149-e159.PubMed van Heerden J, Esterhuizen TM, Hendricks M, et al. The Association of Clinical Characteristics and Tumour Markers With Image-Defined Risk Factors in the Management of Neuroblastoma in South Africa. Clin Oncol (R Coll Radiol) 2022; 34:e149-e159.PubMed
14.
go back to reference Wang H, Li T, Ni X, et al. Image-defined risk factors associated with MYCN oncogene amplification in neuroblastoma and their association with overall survival. Abdom Radiol (NY) 2024; 49:1949–1960.CrossRefPubMed Wang H, Li T, Ni X, et al. Image-defined risk factors associated with MYCN oncogene amplification in neuroblastoma and their association with overall survival. Abdom Radiol (NY) 2024; 49:1949–1960.CrossRefPubMed
15.
go back to reference Jha SK, Brown C, Kang L, et al. Update on the Role of Imaging in Staging of Common Pediatric Abdominal Tumors. Curr Probl Cancer 2023; 47:100969.CrossRefPubMed Jha SK, Brown C, Kang L, et al. Update on the Role of Imaging in Staging of Common Pediatric Abdominal Tumors. Curr Probl Cancer 2023; 47:100969.CrossRefPubMed
16.
go back to reference Chang S, Lin Y, Yang S, et al. Safety and feasibility of laparoscopic resection of abdominal neuroblastoma without image-defined risk factors: a single-center experience. World J Surg Oncol 2023; 21:113.CrossRefPubMedPubMedCentral Chang S, Lin Y, Yang S, et al. Safety and feasibility of laparoscopic resection of abdominal neuroblastoma without image-defined risk factors: a single-center experience. World J Surg Oncol 2023; 21:113.CrossRefPubMedPubMedCentral
17.
go back to reference Monclair T, Mosseri V, Cecchetto G, et al. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group. Pediatr Blood Cancer 2015; 62:1536–1542.CrossRefPubMed Monclair T, Mosseri V, Cecchetto G, et al. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group. Pediatr Blood Cancer 2015; 62:1536–1542.CrossRefPubMed
18.
go back to reference Yu U, Xu H, Chen S, et al. A Retrospective Analysis of the Therapeutic Outcomes of 117 Neuroblastoma Patients Treated at a Single Pediatric Oncology Center in China. Cancer Control 2023; 30:10732748231187837.CrossRefPubMedPubMedCentral Yu U, Xu H, Chen S, et al. A Retrospective Analysis of the Therapeutic Outcomes of 117 Neuroblastoma Patients Treated at a Single Pediatric Oncology Center in China. Cancer Control 2023; 30:10732748231187837.CrossRefPubMedPubMedCentral
19.
go back to reference Luo YB, Cui XC, Yang L, et al. Advances in the Surgical Treatment of Neuroblastoma. Chin Med J (Engl) 2018; 131:2332–2337.CrossRefPubMed Luo YB, Cui XC, Yang L, et al. Advances in the Surgical Treatment of Neuroblastoma. Chin Med J (Engl) 2018; 131:2332–2337.CrossRefPubMed
Metadata
Title
Inter-observer variability in assessing image-defined risk factors: implications for risk stratification in locoregional abdominopelvic neuroblastoma
Authors
Haoru Wang
Mingjing Chen
Ling He
Xin Chen
Publication date
29-10-2024
Publisher
Springer US
Published in
Abdominal Radiology
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-024-04647-4

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Live: Wednesday 29th January, 18:00-19:30 CET

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more